F.D.A. to increase medical radiation oversight

Source: nytimes.com Authors: Walt Bogdanich & Rebecca R. Ruiz The federal Food and Drug Administration said Tuesday that it would take steps to more stringently regulate three of the most potent forms of medical radiation, including increasingly popular CT scans, some of which deliver the radiation equivalent of 400 chest X-rays. With the announcement, the F.D.A. puts its regulatory muscle behind a growing movement to make life-saving medical radiation — both diagnostic and therapeutic — safer. Last week, the leading radiation oncology association called for enhanced safety measures. And a Congressional committee was set to hear testimony Wednesday on the weak oversight of medical radiation, but the hearing was canceled because of bad weather. The F.D.A. has for weeks been investigating why more than 300 patients in four hospitals were overradiated by powerful CT scans used to detect strokes. The overdoses were first discovered last year at Cedars-Sinai Medical Center in Los Angeles, where patients received up to eight times as much radiation as intended. The errors occurred over 18 months and were detected only after patients lost their hair. In making the announcement, the F.D.A. said it hoped to reduce unnecessary radiation exposure from three medical imaging procedures: CT scans, which provide three-dimensional images; nuclear medicine studies, in which patients are given a radioactive substance and doctors watch it move through the body; and fluoroscopies, in which a radiation-emitting device provides a continuous internal image on a monitor. “These types of imaging exams expose patients to ionizing radiation, a [...]

2010-02-09T21:34:45-07:00February, 2010|Oral Cancer News|

The Australian PET Data Collection Project is amassing more evidence that shows that PET positively changes management plans for cancer patients

Source: Journal of Nuclear Medicine (October 2008, Vol. 49:10, pp. 1593-1599) Author: Dr. Andrew Scott et al. Led by Dr. Andrew Scott, director of the Centre for PET at Austin Hospital in Melbourne, the newest research shows that PET provides important prognostic information in a large proportion of patients with untreated head and neck cancer, and detects additional sites of disease. The prospective study, published in the October issue of the Journal of Nuclear Medicine (October 2008, Vol. 49:10, pp. 1593-1599), was conducted at three Australian PET centers between December 17, 2003, and June 3, 2005. The criteria for enrollment included patients who previously had untreated carcinoma of the nasal cavity, nasopharynx, oral cavity, oropharynx, hypopharynx, or larynx, or had metastatic disease involving cervical lymph nodes from an unknown primary. Patients underwent examination under anesthesia and biopsy to confirm their diagnosis of cancer. Contrast-enhanced CT of the neck was required within six weeks of the PET scan. Patients fasted for a minimum of six hours before the PET study and received a dose of 120-440 MBq FDG intravenously. After a minimum uptake period of 45 minutes, researchers acquired PET data from the skull vertex to at least the lower abdomen. Treatment plans Before receiving the results of the PET scans, researchers asked referring clinicians to document their management plan for the patient, as if PET findings were not available, but with access to all other clinical and conventional imaging results. The management plan provided information on options such as surgery, [...]

Go to Top